Oruka Therapeutics, Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Oruka Therapeutics, Inc. (ORKA) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $48.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2018-03-22
- Oruka Therapeutics, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2016-12-31 was $0.00.
- Oruka Therapeutics, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2016-09-30 was $0.00.
- Oruka Therapeutics, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2016 was $48.00K.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $0.00 derived: sum of 2 quarters · filed 2018-03-22 | $48.00K 10-K · filed 2018-03-22 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $48.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $48.00K 10-Q · filed 2017-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |